Skip to main content

News

Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)

Published on August 9, 2017

Uppsala, Sweden and Pickering, Canada, August 9, 2017/CNW/ – Klaria AB (Klaria) (Parent Company, Klaria…

Read More

BIODELIVERY SCIENCES SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA (CANADA) FOR THE LICENSING AND DISTRIBUTION RIGHTS OF BELBUCA® IN CANADA

Published on July 12, 2017

Raleigh, North Carolina (USA) and Pickering, Ontario (CANADA), July 12, 2017/CNW/: Today, BioDelivery Sciences International…

Read More

Purdue Pharma (Canada) appoints Dr. Tom Koutsavlis as new Vice President, Research and Development

Published on July 5, 2017

PICKERING, ON, July 5, 2017 /CNW/ – Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA, has…

Read More

Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P.

Published on June 22, 2017

Dr. Craig Landau Appointed President and CEO Purdue Pharma LP. Read the Press Release issued…

Read More

ARCHIVE

2017
2016
2015
2014
2013
2012

For all media inquiries, please contact:

media@purdue.ca

↓